Sign in
4

Changes in Ownership

Gain Therapeutics, Inc. Filed Acc 0001415889-21-006258

Options or other derivatives

  • CHIEF OPERATING OFFICER acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Alder Matthias CHIEF OPERATING OFFICER 2021-12-23 Grant or award · Non Qualified Stock Option (right to buy) +200,000 $5.86 $1,172,000 200,000 D
Loading xslF345X03/form4-12282021_041202.xml…